Colgate-Palmolive Co. (CL)

Name: Colgate-Palmolive Co. (CL): results, filings decoded, planned insider sales, 13F holders, insiders, Congress and short interest
Creator: GreekSoup
License: https://creativecommons.org/licenses/by/4.0/

Compare with another name

Colgate-Palmolive Co. (CL) reported revenue of $5.4 billion for Q2 FY2026, the quarter ended 30 June 2026, up 4.9% on the same quarter a year earlier. Net income was $693 million, down 6.7% on the year, and diluted earnings per share $0.86. The figures are the company's own, from the 10-Q it filed with the SEC on 31 July 2026.

Revenue$5.4 billionup 4.9%

Net income$693 milliondown 6.7%

Diluted EPS$0.86

QuarterQ2 FY2026ended 30 June 2026

Ratios

From the filings

ROE863.6%

ROCE38.8%

Operating margin14.9%

Net margin9.7%

FCF margin18.3%

Interest cover12.32

Debt to equity33.15

Cash conversion2.19

Share count, 1 year-1.4%

Sales CAGR, 3 years4.3%

Profit CAGR, 3 years6.1%

EPS, TTM$2.53

At the close of 21 September 2026

Price$86.26

Market cap$68.8 billion

Stock P/E34.09

Price to book291.37

EV / EBITDA19.94

Dividend yield2.4%

Market cap / sales3.27

52-week high$99.14

52-week low$74.98

Price, 1 year6.3%

Price CAGR, 3 years6.0%

Price CAGR, 5 years2.4%

Every figure is arithmetic on the filed lines (hover a name for the formula); the priced ones use the latest daily close, CBOE delayed quotes, daily history, by CBOE, for splits. Debt to equity here stands on long-term debt as Colgate-Palmolive Co. files it, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.

Price, 17 September 2021 to 21 September 2026

Show

50-day average 200-day average Volume

Daily closes from CBOE delayed quotes, daily history, by CBOE, for splits; the last is 21 September 2026. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Drawn in your browser; the range and overlay you pick are remembered here only.

The public record on CL

Filings	21 in twelve months: 9 current reports (8-K), about 4 results of operations; 2 exit or disposal costs; 2 officer or director change; 2 other events; 1 shareholder vote
Planned insider sales	11 Form 144 notices in twelve months, $53.5 million; latest 24 August 2026
Options tape	put/call 0.55 by open interest on 23 September 2026; the straddle prices a 1.7% move to 25 September 2026
Holders	11 of the followed funds hold it; largest Geode Capital Management; 2 Schedule 13D or 13G filings in twelve months
Insider trading	14 sales and 0 purchases on Form 4 in twelve months
Congress	3 House trades disclosed in six months
Short interest	17.2 million shares short, 4.17 days to cover at 31 August 2026
Documents	the 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Quarterly results, the last 12 quarters

	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026
Revenue	4,915	4,950	5,065	5,058	5,033	4,945	4,911	5,110	5,131	5,230	5,324	5,361
Cost of revenue	2,038	2,000	2,026	1,992	1,959	1,963	1,924	2,041	2,082	2,084	2,098	2,065
Gross profit	2,877	2,950	3,039	3,066	3,074	2,982	2,987	3,069	3,049	3,146	3,226	3,296
Gross margin	59%	60%	60%	61%	61%	60%	61%	60%	59%	60%	61%	61%
SG&A	1,822	1,803	1,916	1,939	1,979	1,895	1,898	1,963	1,971	2,071	2,076	2,130
Operating income	1,029	1,072	1,047	1,092	1,065	1,064	1,076	1,080	1,059	91.0	964	1,016
Operating margin	21%	22%	21%	22%	21%	22%	22%	21%	21%	2%	18%	19%
Interest expense	n/a	n/a	73.0	78.0	74.0	67.0	66.0	71.0	67.0	63.0	62.0	62.0
Pre-tax income	956	988	967	1,010	986	993	953	1,007	992	107	892	950
Tax rate	22%	23%	25%	24%	21%	22%	24%	23%	23%	104%	24%	24%
Net income	708	718	683	731	737	738	690	743	735	-36.0	646	693
Net margin	14%	15%	13%	14%	15%	15%	14%	15%	14%	-1%	12%	13%
Diluted EPS	$0.86	$0.86	$0.83	$0.89	$0.90	$0.89	$0.85	$0.91	$0.91	-$0.04	$0.80	$0.86
Operating cash flow	1,152	1,136	681	990	1,167	1,269	600	884	1,261	1,453	747	995
Capital expenditure	161	197	126	117	134	184	124	108	155	177	138	128
Free cash flow	991	939	555	873	1,033	1,085	476	776	1,106	1,276	609	867
Buybacks	332	245	509	480	295	455	284	232	288	406	306	291
Shares outstanding	823m	821m	820m	817m	817m	813m	810m	808m	806m	801m	800m	797m
Filing	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Profit and loss, 12 fiscal years and the trailing twelve months

	FY2014	FY2015 †	FY2016 †	FY2017 †	FY2018	FY2019	FY2020	FY2021 †	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	17,277	16,034	15,195	15,454	15,544	15,693	16,471	17,421	17,967	19,457	20,101	20,382	21,046
Cost of revenue	7,168	6,635	6,072	6,174	6,313	6,368	6,454	7,046	7,719	8,131	7,940	8,131	8,329
Gross profit	10,109	9,399	9,123	9,280	9,231	9,325	10,017	10,375	10,248	11,326	12,161	12,251	12,717
Gross margin	58.5%	58.6%	60.0%	60.0%	59.4%	59.4%	60.8%	59.6%	57.0%	58.2%	60.5%	60.1%	60.4%
Research and development	277	274	289	285	277	281	290	307	320	343	355	366	n/a
Selling, general and administrative	5,982	5,464	5,143	5,400	5,389	5,575	6,019	6,407	6,565	7,151	7,729	7,903	8,248
Operating income	3,557	2,789	3,955	3,707	3,694	3,554	3,885	3,332	2,893	3,984	4,268	3,306	3,130
Operating margin	20.6%	17.4%	26.0%	24.0%	23.8%	22.6%	23.6%	19.1%	16.1%	20.5%	21.2%	16.2%	14.9%
Interest expense	134	139	155	156	195	193	184	120	167	287	292	267	254
Pre-tax income	3,533	2,763	3,738	3,487	3,464	3,301	3,647	3,087	2,660	3,392	3,956	3,059	2,941
Income tax	1,194	1,215	1,152	1,313	906	774	787	749	693	937	907	798	779
Effective tax rate	33.8%	44.0%	30.8%	37.7%	26.2%	23.4%	21.6%	24.3%	26.1%	27.6%	22.9%	26.1%	26.5%
Net income	2,180	1,384	2,441	2,024	2,400	2,367	2,695	2,166	1,785	2,300	2,889	2,132	2,038
Net margin	12.6%	8.6%	16.1%	13.1%	15.4%	15.1%	16.4%	12.4%	9.9%	11.8%	14.4%	10.5%	9.7%
Diluted EPS	$2.36	$1.52	$2.72	$2.28	$2.75	$2.75	$3.14	$2.55	$2.13	$2.77	$3.51	$2.63	$2.53
Filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K

Income statement lines from each year's 10-K, the year linked to its filing; TTM is the sum of the last four quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Cash flow and capital returned

	FY2014	FY2015 †	FY2016 †	FY2017 †	FY2018	FY2019	FY2020	FY2021 †	FY2022	FY2023	FY2024	FY2025	TTM
Operating cash flow	3,298	2,949	3,141	3,054	3,056	3,133	3,719	3,325	2,556	3,745	4,107	4,198	4,456
Capital expenditure	757	691	593	553	436	335	409	567	696	705	561	564	598
Free cash flow	2,541	2,258	2,548	2,501	2,620	2,798	3,310	2,758	1,860	3,040	3,546	3,634	3,858
Free cash flow margin	14.7%	14.1%	16.8%	16.2%	16.9%	17.8%	20.1%	15.8%	10.4%	15.6%	17.6%	17.8%	18.3%
Depreciation and amortisation	442	449	443	475	511	519	539	556	545	567	605	630	642
Share-based compensation	131	125	123	127	109	100	107	135	125	122	135	155	178
Buybacks	1,530	1,551	1,335	1,399	1,238	1,202	1,476	1,320	1,308	1,128	1,739	1,210	1,291
Dividend per share	n/a	n/a	n/a	$1.59	$1.66	$1.71	$1.75	$1.79	$1.86	$1.91	$2.48	$2.08	n/a
Diluted shares, weighted	924m	910m	898m	888m	873m	861m	859m	848m	839m	829m	823m	811m	802m
Shares outstanding at period end	907m	893m	883m	875m	863m	855m	850m	840m	830m	821m	813m	801m	797m
Filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K

Buybacks and dividends are the cash paid in the year, from the cash flow statement; the dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet at year end

	FY2014	FY2015 †	FY2016 †	FY2017 †	FY2018	FY2019	FY2020	FY2021 †	FY2022	FY2023	FY2024	FY2025	TTM
Total assets	13,459	11,958	12,123	12,676	12,161	15,034	15,920	15,040	15,731	16,393	16,046	16,330	16,790
Cash and equivalents	1,089	970	1,315	1,535	726	883	888	832	775	966	1,096	1,288	1,370
Receivables	1,552	1,427	1,411	1,480	1,400	1,440	1,264	1,297	1,504	1,586	1,521	1,675	1,962
Inventory	1,382	1,180	1,171	1,221	1,250	1,400	1,673	1,692	2,074	1,934	1,987	2,032	2,181
Goodwill	2,307	2,103	2,107	2,218	2,530	3,508	3,824	3,284	3,352	3,410	3,272	3,122	3,100
Long-term debt	6,132	6,544	6,520	6,566	6,354	7,333	7,334	7,194	8,741	8,219	7,005	7,839	7,823
Operating lease liabilities	n/a	n/a	n/a	n/a	n/a	491	476	451	397	420	456	448	n/a
Shareholders' equity	1,145	-299	-243	-60.0	-102	117	743	609	401	609	212	54.0	236
Filing	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K

At the fiscal year end; the TTM column is the latest quarter end. A line the company does not tag under the usual name is left out.

Compounded growth

	10 years	5 years	3 years	TTM
Sales growth, compounded	2.4%	4.4%	4.3%	5.2%
Profit growth, compounded	4.4%	-4.6%	6.1%	-29.9%
Return on equity, average	n/a	1297.9%	1896.2%	3948.1%

Compounded growth is the latest fiscal year over the year that many years earlier, annualised; the TTM column is the last four quarters over the four before. Return on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Peers: Perfumes, Cosmetics & Other Toilet Preparations

Company	Market cap	P/E	ROE	Op. margin	Sales growth TTM	Debt to equity	Div. yield
Colgate-Palmolive Co. CL	$68.8 billion	34.09	863.6%	14.9%	5.2%	33.15	2.4%
Estee Lauder Companies Inc. EL	$35.1 billion	192.68	4.8%	5.2%	5.0%	1.92	1.5%
Kenvue Inc. KVUE	$33.9 billion	20.55	15.7%	17.1%	1.8%	0.80	4.7%

The names on this site in the same industry (the SEC's SIC description), by market capitalisation. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close.

Filings

Filing	Period	Filed	Where
10-Q	30 June 2026	31 July 2026	EDGAR
10-Q	31 March 2026	1 May 2026	EDGAR
10-K	31 December 2025	23 February 2026	EDGAR
10-Q	30 September 2025	31 October 2025	EDGAR
10-Q	30 June 2025	1 August 2025	EDGAR
10-Q	31 March 2025	25 April 2025	EDGAR
10-K	31 December 2024	13 February 2025	EDGAR
10-Q	30 September 2024	25 October 2024	EDGAR
10-Q	30 June 2024	26 July 2024	EDGAR
10-Q	31 March 2024	26 April 2024	EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install